Insights into potential causes of vascular hyperpermeability in dengue
Dengue is a mosquito-borne disease caused by dengue virus (DENV), where four serotypes can infect humans. Most DENV infections are self-resolving, but in some individuals, severe dengue characterised by a sudden increase in haematocrit, rapid decrease in platelet counts, and vascular leakage is a...
Saved in:
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/160185 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | Dengue is a mosquito-borne disease caused by dengue virus (DENV), where four serotypes
can infect humans. Most DENV infections are self-resolving, but in some individuals, severe
dengue characterised by a sudden increase in haematocrit, rapid decrease in platelet counts,
and vascular leakage is a complication [1,2]. In severe dengue, a major pathogenic mechanism
is a transient increase in vascular permeability resulting in severe plasma leakage (herein
referred to vascular hyperpermeability) leading to hypotension, circulatory collapse, and organ
dysfunction [1]. The precise mechanism in DENV-associated vascular hyperpermeability is
unclear, and several hypotheses including antibody-dependent enhancement (ADE) and
“cytokine storm” have been proposed. In ADE, suboptimal DENV neutralising antibodies
against a heterologous serotype (in secondary infection) promotes DENV uptake into immunological
cells, increasing infection and viral replication that can exacerbate the immune
response [3]. Similarly, infected monocytes release excessive amounts of proinflammatory
cytokines and, if dysregulated, can lead to “cytokine storm” [4]. In this article, we present current
understandings on the potential causes of dengue-associated vascular hyperpermeability,
which is a consequence of complex interactions between the virus and the host endothelium
immune response. |
---|